Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells

Jordi Félez; Lindsey A Miles; Pere Fabregas; Merce Jardi; Edward F Plow; Roger H Lijnen

doi:10.1055/s-0038-1650625

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1996; 76(04): 577-584
DOI: 10.1055/s-0038-1650625

Original Article

Schattauer GmbH Stuttgart

Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells^[*]

Autoren

Jordi Félez

¹Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
Lindsey A Miles

²Department of Vascular Biology, The Scripps Research Institute, La Jolla, CA, USA
Pere Fabregas

¹Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
Merce Jardi

¹Institut Recerca Oncologica (IRO), Hospital Duran i Reynals, Barcelona, Spain
Edward F Plow

³Joseph J. Jacobs Center for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Roger H Lijnen

⁴Center for Molecular and Vascular Biology, University of Leuven, Belgium

Abstract

als PDF herunterladen

Summary

Plasminogen and tPA bind to a common set of binding sites on nucleated cells. To assess the functional consequences of cellular binding, we have measured the kinetic changes induced by plasminogen activation by tPA on cell surfaces. These studies were carried out with U937 and THP-1 monocytoid cells, with Raji, Nalm6 and Molt4 lymphoid cells and with peripheral blood monocytes and neutrophils. The interactions of plasminogen and tPA with cells induced an increase in the rate of plasmin generation which depended upon the cell concentration. With saturating amounts of U937 monocytoid cells (1.25 × 105/ml) the rate of plasmin generation was 0.39 nM.s-1 versus 0.07 and 0.09 nM.s-1 without cells or without tPA, respectively. The catalytic efficiency of Glu- or Lys-plasminogen activation by tPA increased by 7.2- and 24.2-fold, respectively. These changes were induced by a 72-242-fold reduction in the Km of these interactions which was in the range of 0.3-0.9 µM. These values are below the plasminogen concentration in plasma (1-2 µM). Moreover, we provide new data indicating that 1) only a specific subset of plasminogen binding sites, i.e. molecules exposing carboxyl terminal lysines on the cell surface, promotes plasminogen activation on cells; 2) the first four kringles of plasminogen and the finger of tPA are critical for enhanced plasmin generation on cell surfaces; 3) the simultaneous co-localization of tPA with plasminogen on cell surfaces is required for enhanced plasminogen activation; 4) modulation of plasminogen/tPA receptor expression induces concomitant modulation of the stimulatory effects of cells on plasminogen activation and 5) in a direct comparison, the mechanism by which cells and fibrin fragments accelerate plasminogen activation are similar but not identical. These data suggest that modulation of plasminogen/tPA binding sites permits local and efficient generation of plasmin on cell surfaces.

PDF (492 kb)

Referenzen

References
1 Plow EF, Felez J, Miles LA. Cellular Regulation of Fibrinolysis. Thromb Haemost 1991; 66: 32-36
2 Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of Cell-Surface Lysines in Plasminogen Binding to Cells: Identification of alfa-Enolase as Candidate Plasminogen Receptor. Biochemistry 1991; 30: 1682-1691
3 Dudani AK, Pluskota A, Ganz PR. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochem Cell Biol 1994; 72: 126-131
4 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-21197
5 Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin mediated enhancement of t-PA dependent plasminogen activation. J Biol Chem 1994; 269: 21198-21203
6 Lopez-Alemany R, Correc P, Camoin L, Burtin P. Purification of the plas-min receptor from human carcinoma cells and comparison to alpha-enolase. Thromb Res 1994; 75: 371-381
7 Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991; 266: 16730-16735
8 Kanalas JJ, Makker SP. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 1991; 266: 10825-10829
9 Lottenberg R, Broder CC, Boyle MDP, Kain SJ, Schroeder BL, Curtiss R III. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 1992; 174: 5204-5210
10 Dudani AK, Cummings C, Hashemi S, Ganz PR. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 1993; 69: 185-196
11 Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227: 407-415
12 Gonzalez-Gronow M, Gawdi G, Pizzo SV. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. J Biol Chem 1994; 269: 4360-4366
13 Miles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28: 9337-9343
14 Andrade-Gordon P, Strickland S. Interaction of heparin with plasminogen activators and plasminogen: Effects on the activation of plasminogen. Biochemistry 1986; 25: 4033-4040
15 Stack MS, Moser TL, Pizzo SV. Binding of human plasminogen to base-ment-membrane (type IV) collagen. Biochem J 1992; 284: 103-108
16 Stack S, Gonzalez-Gronow M, Pizzo SV. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 1990; 29: 4966-4970
17 Camacho M, Fondaneche M, Burtin P. Limited proteolysis of tumor cells increase their plasmin-binding ability. FEBS Lett 1989; 245: 21-24
18 Felez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA. Competition between Plasminogen and t-PA for Cellular Binding Sites. Blood 1993; 82: 2433-2441
19 Blasi F, Conese M, Moller LB, Pedersen N, Cavallaro U, Cubellis MV. et al The Urokinase Receptor: Structure, Regulation and Inhibitor-mediated Internalization. Fibrinolysis 1994; 8: 182-188
20 Vassalli J. The urokinase receptor. Fibrinolysis 1994; 8: 172-181
21 Dano K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203
22 Bu G, Warshawsky I, Schwartz AL. Cellular Receptors for the Plasminogen Activators. Blood 1994; 83: 3427-3436
23 Felez J, Chanquia CJ, Levin EG, Miles LA, Plow EF. Binding of Tissue Plasminogen Activator to Human Monocytes and Monocytoid Cells. Blood 1991; 78: 2318-2327
24 Felez J, Miles LA, Chanquia CJ, Hickey DM, Dahlberg CM, Plow EF. Competition of The Fibrinolytic Components, Plasminogen and Tissue Plasminogen Activator (t-PA), for Binding Sites on Monocytes and Monocytoid Cells. Thromb Haemost 1991; 65: 878 (A638)
25 Hajjar KA. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. J Biol Chem 1991; 266: 21962-21970
26 Dudani AK, Hashemi S, Aye MT, Ganz PR. Identification of an endothelial cell surface protein that binds plasminogen. Mol Cell Biochem 1991; 108: 133-140
27 Vaughan DE, Mendelsohn ME, Declerc PJ, Van Houtte E, Collen D, Loscalzo J. Characterization of the binding of human tissue-type plasminogen activator to platelets. J Biol Chem 1989; 264: 15869-15874
28 Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519-522
29 Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662
30 Felez J, Miles LA, Plescia J, Plow EF. Regulation of Plasminogen Receptor Expression on Human Monocytes and Monocytoid Cell Lines. J Cell Biol 1990; 111: 1673-1683
31 Gao S, Morser J, McLean K, Shuman MA. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase and streptokinase. Thromb Res 1990; 58: 421-433
32 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-4311
33 Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-2420
34 Ellis V, Scully MF, Kakkar VV. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. J Biol Chem 1989; 264: 2185-2188
35 Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptor. J Biol Chem 1991; 266: 12752-12758
36 Gonzalez-Gronow M, Stack S, Pizzo SV. Plasmin binding to the plasminogen receptor enhances catlytic efficiency and activates the receptor for subsequent ligand binding. Arc Biochem Biophys 1991; 286: 625-628
37 Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 1987; 80: 1712-1719
38 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257: 2912-2919
39 Lijnen HR, Van Hoef B, Collen D. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen. Thromb Res 1990; (Suppl. 57) Suppl 10: 45-54
40 Dodd I, Mitchell DL, Entwisle C, Browne MJ, Robinson JH. Susceptibility of mutant, recombinant plasminogen activators to proteolytic breakdown: Removal of the F domain by plasmin. Fibrinolysis 1993; 7: 237-241
41 Sturzebecher J, Newmann U, Kohnert U, Kresse GB, Fischer S. Mapping of the catalytic site of CHO-tPA and the y-PA variant BM 06.022 by synthetic inhibitors and substrates. Protein Science 1992; 1 (08) 100-113
42 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1995-1996
43 Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry 1986; 25: 6926-6933
44 Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen. In: Isolation of two lysine-binding fragments and one “mini-”plasminogen (MW 38,000) by elastase-cata-lyzed-specific limited proteolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3. New York: Raven Press 1978. 191-209
45 Phillips DR, Morrison M. Exposed protein on the intact human erythrocyte. Biochemistry 1971; 10: 1766-1771
46 Zamarron C, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. J Biol Chem 1984; 259 (04) 2080-2083
47 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
48 Granelli-Pipemo A, Vassalli J, Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. J Exp Med 1989; 146: 1693-1705
49 Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009
50 Sehl LC, Castellino FJ. Thermodynamic properties of the binding of a-, omega-amino acids to the isolated kringle 4 region of human plasminogen as determined by high sensitivity titration calorimetry. J Biol Chem 1990; 265: 5482-5486
51 McCance SG, Menhart N, Castellino FJ. Amino acid residues of the krin-gle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. J Biol Chem 1994; 269: 32405-32410
52 Hoyer-Hansen G, Ronne E, Solberg H, Behrendt N, Ploug M, Lund LR. et al Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992; 267: 18224-18229
53 Miles LA. Regulation of fibrinolysis and proteolysis by plasminogen receptors. Biol Clin Hematol 1993; 15: 107-115
54 Beebe DP, Miles LA, Plow EF. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 1989; 74: 2034-2037

Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells[*]

Autoren

Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells^[*]